» Authors » Julie Heroux

Julie Heroux

Explore the profile of Julie Heroux including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 167
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Panay N, Nappi R, Stute P, Palacios S, Paszkowski T, Kagan R, et al.
Maturitas . 2023 Apr; 172:23-31. PMID: 37084589
Objectives: The Women's Health Initiative study reported an increased risk of venous thromboembolism among menopausal women treated with conjugated equine estrogens/medroxyprogesterone acetate (CEE/MPA) versus placebo. Newer hormone therapies may have...
2.
Eisman J, Cortet B, Boolell M, Ionescu-Ittu R, Vekeman F, Heroux J, et al.
Osteoporos Int . 2023 Mar; 34(5):977-991. PMID: 36872338
Purpose: Using a US claims database (2009-2019), we compared risk of fractures between women with osteoporosis initiated on gastro-resistant (GR) risedronate and those initiated on (a) immediate release (IR) risedronate...
3.
Siegfried E, Paller A, Mina-Osorio P, Vekeman F, Kaur M, Mallya U, et al.
BMC Dermatol . 2020 Dec; 20(1):24. PMID: 33341118
Background: An estimated 50% of children in the US are Medicaid-insured. Some of these patients have poor health literacy and limited access to medications and specialty care. These factors affect...
4.
Paller A, Siegfried E, Vekeman F, Gadkari A, Kaur M, Mallya U, et al.
J Am Acad Dermatol . 2019 Aug; 82(3):651-660. PMID: 31400453
Background: Real-world evidence on treatment patterns of pediatric patients with atopic dermatitis (AD) is sparse. Objective: To assess current treatment patterns in pediatric AD patients. Methods: Retrospective observational analysis of...
5.
Maziarz R, Guerin A, Gauthier G, Heroux J, Zhdanava M, Wu E, et al.
Int J Hematol Oncol . 2018 Oct; 5(2):63-75. PMID: 30302205
Aim: To assess the 5-year healthcare resource utilization (HRU) and direct payer costs following allogeneic hematopoietic stem cell transplants (HSCTs) in acute lymphoblastic leukemia pediatric patients using data from two...
6.
Shiozawa A, Cloutier M, Heroux J, Guerin A, Wu E, Jackson R
Curr Med Res Opin . 2015 Jun; 31(8):1611-20. PMID: 26086788
Objective: To describe real-world treatment patterns of patients receiving colchicine or other treatments during a gout-related emergency room or acute care facility (ER/ACF) visit. Methods: An online physician-administered questionnaire was...
7.
Lachaine J, De G, Sikirica V, van Stralen J, Hodgkins P, Yang H, et al.
Can J Psychiatry . 2015 Jan; 59(11):597-608. PMID: 25565476
Objective: To assess treatment patterns, health care resource utilization (HRU), and costs among previously stimulant-treated children and adolescents with attention-deficit hyperactivity disorder (ADHD) receiving atypical antipsychotic (AAP) prescriptions in Quebec....
8.
Heroux J, Moodie E, Strumpf E, Coyle N, Tousignant P, Diop M
Stat Med . 2013 Oct; 33(7):1205-21. PMID: 24167024
Evaluating the impacts of clinical or policy interventions on health care utilization requires addressing methodological challenges for causal inference while also analyzing highly skewed data. We examine the impact of...
9.
Ohayon J, Finet G, Le Floch S, Cloutier G, Gharib A, Heroux J, et al.
Ann Biomed Eng . 2013 Sep; 42(2):269-79. PMID: 24043605
Coronary atheroma develop in local sites that are widely variable among patients and are considerably variable in their vulnerability for rupture. This article summarizes studies conducted by our collaborative laboratories...
10.
Ohayon J, Gharib A, Garcia A, Heroux J, Yazdani S, Malve M, et al.
Am J Physiol Heart Circ Physiol . 2011 Jun; 301(3):H1097-106. PMID: 21685261
Coronary bifurcations represent specific regions of the arterial tree that are susceptible to atherosclerotic lesions. While the effects of vessel compliance, curvature, pulsatile blood flow, and cardiac motion on coronary...